| Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development P Pandey, JS Rane, A Chatterjee, A Kumar, R Khan, A Prakash, S Ray Journal of Biomolecular Structure and Dynamics 39 (16), 6306-6316, 2020 | 292 | 2020 |
| Blood brain barrier: a challenge for effectual therapy of brain tumors A Bhowmik, R Khan, MK Ghosh BioMed research international 2015, 2015 | 265 | 2015 |
| Azithromycin in combination with riboflavin decreases the severity of Staphylococcus aureus infection induced septic arthritis by modulating the production of free … P Mal, K Dutta, D Bandyopadhyay, A Basu, R Khan, B Bishayi Inflammation Research 62, 259-273, 2013 | 46 | 2013 |
| Nucleic acid-based therapy for coronavirus disease 2019 R Piyush, K Rajarshi, A Chatterjee, R Khan, S Ray Heliyon 6 (9), 2020 | 38 | 2020 |
| Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19 K Rajarshi, R Khan, MK Singh, T Ranjan, S Ray, S Ray Gene 768, 145313, 2021 | 29 | 2021 |
| Targeting virus–host interaction by novel pyrimidine derivative: an in silico approach towards discovery of potential drug against COVID-19 JS Rane, P Pandey, A Chatterjee, R Khan, A Kumar, A Prakash, S Ray Journal of Biomolecular Structure and Dynamics 39 (15), 5768-5778, 2021 | 28 | 2021 |
| Convalescent plasma therapy: a promising coronavirus disease 2019 treatment strategy R Piyush, K Rajarshi, R Khan, S Ray Open Biology 10 (9), 200174, 2020 | 23 | 2020 |
| Formulation and antitumorigenic activities of nanoencapsulated nifetepimine: A promising approach in treating triple negative breast carcinoma A Ghosh, A Bhowmik, S Bhandary, S Putatunda, A Laskar, A Biswas, ... Nanomedicine: Nanotechnology, Biology and Medicine 12 (7), 1973-1985, 2016 | 7 | 2016 |
| Phytochemicals as anticancer drugs: Targeting the microtubular network of cancer cells R Khan, A Chatterjee, H Ghosh, S Kapoor, S Ray Phytochemistry: An in-silico and in-vitro Update: Advances in Phytochemical …, 2019 | 4 | 2019 |
| Bacterial Cell Division Machinery: An Insight for Development of New Antibacterial Agent R Khan, S Ray Phytochemistry: An in-silico and in-vitro Update: Advances in Phytochemical …, 2019 | 2 | 2019 |
| Arylcoumarin perturbs SARS-CoV-2 pathogenesis by targeting the S-protein/ACE2 interaction R Singh, A Kumar, JS Rane, R Khan, G Tripathi, AK Ajay, A Prakash, ... Scientific Reports 12 (1), 17038, 2022 | | 2022 |
| NHS Innovation Accelerator: Understanding how and why the NHS adopts innovation NHS S Roberts, S Powis, A Begley, L Boyd, A Chatterjee, S Jenkins, R Tailor, ... | | 2022 |
| An Intimate Alliance of DNA-Damage Response Network with Cell-Cycle Checkpoints Amid Events of Uncontrolled Cellular Proliferation: A Mini-Review A Chatterjee, K Rajarshi, R Khan, H Ghosh, S Kapoor, S Ray Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2021 | | 2021 |
| After the storm; 6-month follow up outcomes and management of COVID-19 related venous thromboembolism M Ahmed, R Khan, E Xenou, M Fowler, S Sinha, A Lokare, C Kartsios Research and Practice in Thrombosis and Haemostasis, 2021 | | 2021 |
| Targeting virus-host interaction: An in silico approach to develop promising inhibitors against COVID-19 JS Rane, A Chatterjee, R Khan, A Kumar, S Ray | | 2020 |
| An intimate alliance of DNA-damage response network with cell-cycle checkpoints amid events of uncontrolled cellular proliferation-a mini review R Khan OSF, 0 | | |
Shashikant RayMahatma Gandhi Central University Motihari BiharVerified email at mgcub.ac.in
